Gene module analysis of juvenile myelomonocytic leukemia and screening of anticancer drugs

Area of Science:

• Pediatric Oncology
• Bioinformatics
• Molecular Biology

Background:

• Juvenile myelomonocytic leukemia (JMML) is a rare, severe childhood cancer with no specific therapies.
• The underlying gene expression alterations in JMML remain largely uncharacterized.

Purpose of the Study:

• To identify molecular targets and biomarkers for JMML diagnosis, treatment, and prognosis.
• To explore novel therapeutic strategies for JMML.

Main Methods:

• Microarray data analysis using Gene Expression Omnibus.
• Construction of protein-protein interaction networks for differentially expressed genes.
• Bioinformatics analysis including Gene Ontology and KEGG pathway enrichment.

Main Results:

• Identification of four core functional modules in JMML.
• Discovery of nine potential anticancer drugs targeting JMML-associated genes via CMap database.
• Identification of regulatory miRNAs and transcription factors involved in JMML gene expression.

Conclusions:

• This research provides a comprehensive molecular landscape of JMML.
• Potential therapeutic targets and diagnostic biomarkers have been identified.
• A novel research strategy for developing JMML-targeted chemotherapies is proposed.